开放腹壁疝修补中生物合成网片与聚丙烯网片的早期伤口并发症比较
本研究基于美国疝协会质量协作组数据,比较2013年至2016年择期开放腹壁疝修补中使用生物合成网片或未涂层聚丙烯网片的患者,在清洁-污染或污染切口中的30天伤口结局。倾向性匹配分析显示,生物合成网片组的手术部位感染、需干预的手术部位事件和再手术率均显著高于聚丙烯网片组,而手术部位事件总体发生率及非计划再入院率无显著差异。
要点
- 在清洁-污染或污染切口的择期开放腹壁疝修补中,生物合成网片的30天伤口并发症高于聚丙烯网片。
- 生物合成网片组手术部位感染率、需干预的手术部位事件率和再手术率显著更高。
- 两组总体手术部位事件发生率和非计划再入院率无显著差异。
核心结论
- 在择期开放腹壁疝修补的清洁-污染或污染切口中,生物合成网片相比聚丙烯网片与更高的30天伤口并发症相关。
研究设计与样本
- 基于美国疝协会质量协作组的回顾性队列研究,纳入2013年1月至2016年10月所有择期开放腹壁疝修补使用生物合成网片或未涂层聚丙烯网片的病例。
- 采用1:3倾向性匹配分析,评估网片类型与清洁-污染或污染伤口30天伤口事件的关系。
主要发现
- 生物合成网片占择期开放腹壁疝修补的8.5%(175/2051),其中57.1%用于低风险或合并症清洁病例。
- 匹配分析中,生物合成组与聚丙烯组30天手术部位事件发生率分别为20.7%和16.7%(p=0.49),非计划再入院率分别为13.8%和9.8%(p=0.4),均无显著差异。
- 生物合成组手术部位感染率显著更高(22.4% vs 10.9%,p=0.03)。
- 生物合成组需干预的手术部位事件率显著更高(24.1% vs 13.2%,p=0.049)。
- 生物合成组再手术率显著更高(13.8% vs 4.0%,p=0.009)。
临床怎么用
- 在择期开放腹壁疝修补的清洁-污染或污染切口中选择网片时,需权衡生物合成网片较高的早期伤口并发症风险。
- 生物合成网片的应用应审慎,尤其需关注手术部位感染、干预和再手术风险。
局限性
- 需要更多上市后分析以明确污染腹壁疝修补的最佳网片选择、放置位置和手术技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recently introduced slow-resorbing biosynthetic and non-resorbing macroporous polypropylene meshes are being used in hernias with clean-contaminated and contaminated wounds. However, information about the use of biosynthetic meshes and their outcomes compared with polypropylene meshes in clean-contaminated and contaminated cases is lacking. Here we evaluate the use of biosynthetic mesh and polypropylene mesh in elective open ventral hernia repair (OVHR) and investigate differences in early wound morbidity after OVHR within clean-contaminated and contaminated cases. STUDY DESIGN: All elective, OVHR with biosynthetic mesh or uncoated polypropylene mesh from January 2013 through October 2016 were identified within the Americas Hernia Society Quality Collaborative. Association of mesh type with 30-day wound events in clean-contaminated or contaminated wounds was investigated using a 1:3 propensity-matched analysis. RESULTS: Biosynthetic meshes were used in 8.5% (175 of 2,051) of elective OVHR, with the majority (57.1%) used in low-risk or comorbid clean cases. Propensity-matched analysis in clean-contaminated and contaminated cases showed no significant difference between biosynthetic mesh and polypropylene mesh groups for 30-day surgical site occurrences (20.7% vs 16.7%; p = 0.49) or unplanned readmission (13.8% vs 9.8%; p = 0.4). However, surgical site infections (22.4% vs 10.9%; p = 0.03), surgical site occurrences requiring procedural intervention (24.1% vs 13.2%; p = 0.049), and reoperation rates (13.8% vs 4.0%; p = 0.009) were significantly higher in the biosynthetic group. CONCLUSIONS: Biosynthetic mesh appears to have higher rates of 30-day wound morbidity compared with polypropylene mesh in elective OVHR with clean-contaminated or contaminated wounds. Additional post-market analysis is needed to provide evidence defining best mesh choices, location, and surgical technique for repairing contaminated ventral hernias.
引用
- Sahoo S, Haskins IN, Huang LC, et al. Early Wound Morbidity after Open Ventral Hernia Repair with Biosynthetic or Polypropylene Mesh. J Am Coll Surg. 2017. PMID: 28826804. doi:10.1016/j.jamcollsurg.2017.07.1067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。